corresponding

Related by string. corresponds * * includes corresponding Graph . corresponding period . corresponding fixture . corresponding buttons . Corresponding author . includes corresponding Graphs . Corresponding Secretary . Corresponding Author . REpower corresponding . corresponding reconciliations . includes Corresponding Graph . Corresponding Days . nouns corresponding *

Related by context. All words. (Click for frequent words.) 56 Corresponding 51 preceding 50 approximated 50 corresponds 49 ended September# 49 prioryear 49 compared 49 corresponding period 48 sameperiod 48 corresponded 48 comparable 47 anincrease 47 approximate 47 ascompared 47 HUF#.# billion [002] 46 #.#bn rub [003] 46 comparedto 46 #.#bln rbl [003] 46 b Reflects 46 of#.# [004] 46 theprior 46 CHF #'#'# 46 sequential 45 glutamate glutamine 45 MOP#.# billion [001] 45 correspondingly 45 Positively impacting 45 Fig. 1a 45 -Louise Hawkley 45 nonoverlapping 45 respectively 45 -#.# Mio 45 tracer uptake 45 postintervention 44 decreased 44 prior 44 EBIT amounted 44 MVAS gross 44 #.# crore [004] 44 totalized 44 specified 44 #.# crore [002] 44 consequent 44 EUR1 #.#m 44 EBITA amounted 44 Adjusted EBITDA1 43 quarter# 43 #.#bn rub [002] 43 #.#mln rub [006] 43 actual 43 Eustat data 43 decrease 43 #.#mln [007] 43 #.#mln rub [001] 43 correspond 43 #.#mlrd rbl [002] 43 Xth Plan 43 #.#mln [006] 43 #.#mln rub [002] 43 approx. USD#.#m [001] 43 LTL #mn [001] 43 BPLP 43 same 43 #.#mln rub [005] 43 RMB#.# [001] 43 comparedwith 43 Non GAAP adjusted EBITDA 43 Divestco generated 43 Pro forma Adjusted EBITDA 43 orthologous genes 43 #.# crores [001] 43 quarter offiscal 43 #.#mlrd rbl [001] 43 atneed 43 Inventories subtracted 43 reached Dhs#.#m 43 2Q FY# [001] 42 RON# [002] 42 theprevious 42 correlating 42 #.#pps y y 42 9M FY# [002] 42 Hazard Ratio HR 42 MNOK #.# 42 Fig. 4a 42 3Q FY# representing 42 heterozygosity LOH 42 #.# mil rub [002] 42 SEK -#.# -#.# [003] 42 Replikin Count 42 ie 42 retrospectively adjusted 42 unrealized derivative gain 42 TEUR -# 42 EnPro consolidated 42 monotonically 42 #.#bln rbl [002] 42 ASUR regulated 42 φ 42 totaled LVL 42 d Reflects 42 3Q FY# 42 CHF #'# [002] 42 Rs.#.#cr 42 totaled MEUR 42 USD#.#m [007] 42 mEUR 42 efficiency ratio teb 42 Pacific hake whitefish 42 Q1 #F 42 Q#-Q#/# [001] 42 compares 42 thethird quarter 42 recomputed 42 g Represents 42 Largely offsetting 42 graph illustrating 42 H# [004] 42 neuroD2 42 EUR -#.# [001] 41 invoiced shipments 41 SEK -#.# [002] 41 Prepaid churn 41 Scrap intake 41 principally attributable 41 Mn USD 41 totaled EUR#.#m 41 affective psychosis 41 Negatively impacting 41 yearago 41 RMB#.# billion [001] 41 comparative 41 RUR #,#.# 41 MEUR -#.# 41 gadolinium enhancing T1 41 Dhs2 #m 41 allelic 41 ofapproximately 41 Wireline EBITDA 41 Non IFRS 41 Q4 FY# [001] 41 sensory gating 41 c Represents 41 y axis 41 totaled E#.# 41 #,#.# MEUR 41 operatingincome 41 repricing downward 41 TRY#.# [005] 41 Multifactor productivity 41 #-#/# [013] 41 unfavorable variance 41 KSH detected 41 Ps.#.# [001] 41 Partially offset 41 and#.# [002] 41 logistic regression model 41 Noninterest expense totaled 41 primarily attributable 41 Fig. 3b 41 #mln rub [001] 41 USc lb 41 Summarized consolidated 41 Rs#mn [001] 41 ay y 41 date CYTD 41 recasted 41 fractional shortening 41 normalized FFO guidance 41 onyear 41 USD#.#m [008] 41 noninterest expense totaled 41 RUR#.#bn approx. USD#m [003] 41 GDP deflator broad 41 #.# crore [001] 41 SEK1 #m 40 #.#mln rbl [003] 40 QIV 40 #.#per diluted 40 velocity vector 40 Paid clicks 40 comparing favorably 40 gastric antrum 40 PDP MLR 40 Kubuntu Edubuntu 40 #.# Crores [001] 40 FII shareholding 40 #Q/# [001] 40 LIFO inventory 40 hemagglutinin gene 40 FHLB borrowings decreased 40 sine cosine 40 β = 40 deletes incorrect 40 Q3 LY 40 elexis 40 #.#pps [001] 40 OREO write downs 40 thd tons 40 Earning Per Share 40 totaled EUR#.# 40 sm Nasdaq NDAQ 40 #,# mln 40 RevPAR ADR 40 Rmb #.# 40 MSEK -#.# 40 noninterest expense divided 40 tabular formats 40 f Reflects 40 regression coefficients 40 Isomedix Services 40 bipyridine 40 Headline PBIT 40 Asterisks indicate 40 CZK#.# billion [001] 40 abovementioned 40 noninterest expense decreased 40 PBDIT 40 increaseof 40 RMB4 #.# 40 #-#/# EUR 40 Q#FY'# 40 MSEK -# [002] 40 Unadjusted 40 RUR#.#bn approx. USD#.#bn [003] 40 OCF margin 40 rateof 40 Q2 #F 40 thequarter 40 CD8 cell 40 #.#bn rub [004] 40 inter segmental 40 ninemonths 40 offiscal 40 Statscan revised 40 similarly captioned 40 Rating Scale IRLS 40 nine monthsended 40 Adjusted Ebitda 40 of# [001] 40 AED #,#,#,# 40 EUR -#.# [003] 40 #.# trln rbl 40 left ventricular diastolic 40 approximating 40 flattish sequentially 40 Extra Ordinary Items 40 RO#.# [006] 40 subsequent 40 Kaplan Meier survival 40 sequentially 40 Ps.3 40 CNY#.# [001] 40 RMB#.# billion [003] 40 EBITDAA 40 iii Ps 40 Gross Profit Gross 40 was#.# 40 LPA gene 40 amortized ratably 40 NOK#.# [006] 40 EEK #mn 40 Supplementary Table 40 OSV segment 40 associated therewith 40 Programmer Paradise segment 40 increased 40 Unfavorable currency 40 Q#/# EUR [002] 40 ALLL ratio 40 confidence intervals CIs 40 months endedSeptember 40 Rs.#.# lakhs [002] 40 partially counteracted 40 yo y 40 serum PTH 40 -# TEUR 40 QR1 #,#,# 40 SEK -#.# [001] 40 nulls 40 #mln rub [002] 40 b Represents 40 coupon redemptions 40 EUR #,# Mio 39 operands 39 FTE staffing 39 correlated 39 TEB adjustment 39 Rs.#.# crore [010] 39 unannualized 39 Rs.#.# Crores [004] 39 Business.com Acquisition 39 USD#.#m USD#.# per [002] 39 Recurrent expenditure 39 ESA# 39 RMB7 39 Rs.#.# Crores [003] 39 JPY5 39 PY EUR 39 nonconvertible debt borrowing 39 Timeshare segment 39 WOMAC pain 39 Ps.1 #.# 39 Slight variations 39 sorted alphabetically 39 condensed consolidated 39 Ps.#.# [007] 39 GVIC consolidated 39 1Q FY# 39 Appreciable 39 cumulated 39 QR#.#bn [007] 39 #compared 39 whereas 39 #bps qoq [001] 39 Q#/# EUR [001] 39 Adjusted EBITDAR margin 39 figs. 39 Supplementary Fig 39 serum BDNF 39 RUR#.# [006] 39 Q1 FY'# 39 Q1 LY 39 multiplanar 39 b Excludes 39 #-#/# [004] 39 Annualised 39 RUB #.# [001] 39 undepreciated assets 39 increasein 39 4Q FY# 39 fiscal year# 39 postcards periodicals 39 JPY#.# billion [002] 39 f Represents 39 Å -1 39 laterality 39 H#/# EUR 39 Fig. 1A 39 rotational symmetry 39 retinal edema 39 Rs.#.# crore [002] 39 Blended ARPU 39 diagram illustrates 39 fig. S4 39 interphase 39 Fig. 4b 39 quadrillion TL 39 disaggregates 39 #.# Crores [003] 39 maturational 39 fig. S2 39 EBITDAF 39 Consolidated EBITDAR 39 impacting comparability 39 RMB#.# [007] 39 Fig. 1b 39 #.#mn [001] 39 bn RUR 39 sows farrowed 39 Normalised 39 Fitch BBB medians 39 tCO2e 39 NIS #.#b [001] 39 ascribable 39 Single nucleotide polymorphisms 39 SEK#.#m [002] 39 FHLB advances decreased 39 Fig. 2a 39 HUF#.# billion [001] 39 underpredicted commodity price 39 eigenvalue 39 #.#x DSCR 39 denoted 39 decreases 39 MMSE score 39 QUALCOMM pro forma 39 cumulative 39 MPRs 39 c Relates 39 PBIDT 39 Rs#.#mn [002] 39 LTL #.#mn [003] 39 Ps.2 39 mRNA encoding 39 to#.# [006] 39 securitization exposures 39 Loss severities 39 ERK activation 39 per MCFE 39 Refractories segment 39 clinicopathological features 39 trln rbl 39 MXN# #mn 39 warranty accruals 39 interannual 39 phytoplankton biomass 39 seropositivity 39 orthologous 39 Rs.#.# crores [005] 39 Lm#.# [003] 39 commutative 39 PLN #.#mn [001] 39 BGN #,# [002] 39 BRL#.# [001] 39 Gross Margin Gross 39 resulting 38 asterisk denotes 38 contralateral 38 EUR #,# 38 fractional anisotropy 38 Noninterest expense decreased 38 USD#.#m USD#.# [002] 38 intersegment transactions 38 RMB#.# [008] 38 #.#mln [004] 38 bn rub 38 previous 38 Pricing varies depending 38 paternally inherited 38 Chilled pork 38 virtually identical 38 millioncompared 38 operating EBIDA 38 RMB#.# [003] 38 Fig. 1d 38 Adjusted EBIT 38 GTP binding 38 perfusion defect 38 FDIC indemnification 38 Ps 38 fis cal 38 concomitant 38 fluorescence intensity 38 CDAI score 38 sunitinib sorafenib 38 billion soums 38 RMB#.#million 38 JPY9 38 logarithmic 38 SEK#.#m [003] 38 H1 FY# [001] 38 underlift 38 #-#.# [019] 38 Rs#.# crore [007] 38 #F YTD 38 reconciles GAAP 38 #.# perdiluted 38 excluding BIBP 38 reports yicai.com citing 38 Wireline adjusted EBITDA 38 thsd 38 spectral reflectance 38 cortical activation 38 chromatograms 38 vs. #M# 38 TRY#.# billion 38 PGP Acquisition 38 surge inland Suhayda 38 adjusted2 38 RGU additions 38 Wafer shipments 38 unfavorable variances 38 #.#/diluted share 38 tropospheric temperature 38 DKK#m [002] 38 sub millisecond latency 38 Supplemental Table 38 Real disposable incomes 38 EBITD 38 digit numeric 38 Mantel Haenszel 38 Excluding OSIs 38 cesium atom 38 outturn represents 38 Panlab 38 2D 4D 38 EUR# mn [001] 38 interpretability 38 multivariate regression 38 LBITDA 38 #M# [002] 38 posterior cingulate 38 E#.# [003] 38 andoperating 38 minus TEUR 38 prostate gland mammary gland 38 SBS Balancer segment 38 #.# mil rub [003] 38 #.#bln [004] 38 chromatogram 38 unrounded 38 horizontal axis 38 EBIT beia 38 RAD SVT 38 million1 representing 38 orthologs 38 user definable 38 Rs #.# [001] 38 Billable headcount 38 SEK #,#,#.# 38 SEK -# 38 urine excretion 38 Marketwide 38 Rs #,#.# [002] 38 Rs#.#cr [001] 38 perceptible 38 #H/# 38 totaled AZN 38 Figure 1A 38 AZN #mln [002] 38 Gross profit 38 FQ = fiscal 38 Imputed Revenue 38 adjusted 38 PER2 38 #.#mln rub [004] 38 RUB #.# [002] 38 Rs.#.# crores [004] 38 Kronos TiO2 production 38 Verizon SuperPages yellow 38 insertions deletions 38 Rosebel royalty 38 CYP #k 38 thetotal 38 #.#pc yr yr 38 Adjusted EBT 38 afferent 38 mrad 38 NOK#.# billion [001] 38 subscriber activations 38 up#.# [002] 38 Eustat 38 Fine Chemicals segment 38 Bree Tanner newborn 38 Supplementary Figs 38 PTOI 38 PMPM basis 38 Rs#cr Rs#cr [002] 38 computed 38 microstructural 38 TMPRSS2 ERG fusion 38 identical 38 outstanding DSOs 38 ARCALYST ® 38 pagesjaunes.fr 38 from#.# [001] 38 #.#bln [006] 38 comma delimited 38 footnotes thereto 38 CHF#.# billion [002] 38 CHD mortality 38 accordance 38 Figure 1C 38 drilldown 38 nonGAAP 38 Normalised earnings 38 Cronbach alpha 38 CSDs Dr Pepper 38 Rs.#.# lakhs [004] 38 Hole IKD 38 pulse amplitude 38 client reimbursables 38 http:/www.torchmarkcorp.com 38 BVPS 38 Platelet counts 38 EURO#.# [002] 38 #bps QoQ [002] 38 non gaap 38 adjusted EBITDAS 38 kilometers RPK 38 reflecting 38 #,#.# crore 38 inbreeding coefficient 38 +#,# % [002] 38 equilibrating 38 fructosamine 38 DPAC amortization 38 DKK 38 observable traits 38 LIFO adjustment 38 #.# lacs [001] 38 #.#mln rub [007] 38 MVAS revenues 38 EUR2 #mn 38 anisotropy 38 DGCIS 38 dI dV 38 intersegment 38 Barocycler instruments 38 totaled RUB 38 countryТs 38 reconciles EBITDA 38 Rs.#.# crores [003] 38 ADCS ADL 38 predefined 38 Remainco 38 nonobese 38 frontal temporal 38 NTIC joint ventures 38 Rs.# #,#,# 38 earnings pershare 38 ADMTs 38 Chemicals Segment 38 #.# crores [003] 38 #were 38 1Q FY# representing 38 Workplace Relations skilled 38 KZT# 37 Explosive Metalworking segment 37 regression coefficient 37 Consolidated OIBDA 37 #Q# [005] 37 #.# bn [002] 37 theperiod 37 #.#bn rub [005] 37 serum bicarbonate 37 interquartile range 37 Ps.4 37 #MFY# [001] 37 RUB #.#bn approx. USD [001] 37 window.open 37 mV V 37 binary restenosis 37 LTL #mn [002] 37 Shipment volumes 37 reached LL#.# trillion 37 twelve 37 azimuthal 37 discernable 37 Raheem Suleman Talk 37 EUR -#.# -#.# [001] 37 voxels 37 IQR 37 correlated inversely 37 ay y decline 37 Excludes unrealized 37 incremented 37 bln RUR 37 LIFO inventory valuation 37 Prepaid ARPU 37 headers footers 37 Romaco segment 37 normalized biomarker 37 histograms 37 proinflammatory mediators 37 noninterest expense partially offset 37 #bps YoY [002] 37 Fig. 1D 37 UAH #.#mn [001] 37 #.# bn [001] 37 contributable 37 Dhs1 #m 37 RVUs 37 HOMA IR 37 Pearson correlation coefficient 37 RUB#.#bn [001] 37 by#.# [002] 37 receivables payables 37 #.# bln rbl [003] 37 retroactively restated 37 tonnage milled 37 graph illustrates 37 fig. S1 37 applicable 37 Annualizing 37 Q#/# € 37 fig. S8 37 HbA1C levels 37 serum sodium concentration 37 RUB#.# billion [001] 37 Fig. 2A 37 MagTex acquisition 37 atheroma volume 37 Rs.#.# crores [009] 37 CIBIC + 37 INR #.# [002] 37 #.#:#.# [002] 37 cystoscopic 37 metabolite concentrations 37 Bezeq Fixed Line 37 approx. USD# 37 amortizable intangible assets 37 #.# crore [003] 37 of#.# [001] 37 aforementioned 37 SEK #.#M #.# 37 Wireless postpaid subscriber 37 intima media thickness IMT 37 E1 #Mn 37 condensed consolidated balance sheets 37 millionfor 37 #.#mln rbl [004] 37 Pigments segment 37 #.#,# [007] 37 frontostriatal 37 by#.# [001] 37 Rs.#.# Crores [001] 37 Corrugated container 37 Histologic 37 Kasco segment 37 mRNA transcripts 37 DKK #,#,# 37 segmental duplications 37 TRY1 #.# 37 EBTIDA 37 RO#.# [002] 37 intergenic regions 37 recoded 37 threemonths ended 37 Variable Interest Entities VIEs 37 Rs#.#mn [001] 37 GenBank accession 37 Kerastick ® 37 fiducials 37 #.#Mn [001] 37 immunoreactive 37 Medicare Advantage MLR 37 LIFO accounting 37 multivariate adjustment 37 totaled BRL#.# 37 definite stent thrombosis 37 #M/# 37 rho = 37 synchronously 37 anaverage 37 MNOK 37 Ab# 37 and#.# [001] 37 MMdM 37 Q#-#/# 37 apparent diffusion coefficient 37 Fully diluted EPS 37 Nonresidential structures 37 Suezmax fleet 37 Seroconversion 37 fiscalyear 37 ended December# 37 #N #N 37 Ps.1 37 CRNs 37 excludes unrealized gains 37 ferroalloy segment 37 noncash amortization 37 Yr Yr 37 predefine 37 Fig. 2c 37 UAH #.#mn [004] 37 Fig. 2D 37 Rigid PCB shipments 37 #.#mln [002] 37 autocorrelation 37 XO HOLDINGS INC. 37 TOP2A gene 37 Gradebook teachers 37 D#.# [003] 37 visually depict 37 bn manats 37 characteristic impedance 37 Gaussian distribution 37 Graphical representation 37 to#.# [003] 37 nausea emesis 37 MYR# #mn 37 seventeenth consecutive 37 mineralized sandstone 37 FASB #R 37 SHFAs 37 #.#/ADR increasing 37 EURO# [002] 37 Truckload segment 37 absorptions 37 Fig. 3B 37 LDB CPR 37 endedSeptember 37 LTL #.#mn [002] 37 Slightly offsetting 37 Note Certain reclassifications 37 Pricing varies 37 MARRIOTT REVENUES totaled 37 #.#mln ton [001] 37 leukocyte telomere length 37 trisomic 37 urodynamic 37 RUR#.#bn approx. USD#.#m [001] 37 9M FY 37 Breslow thickness 37 E#Mn [002] 37 n#.# [001] 37 FTE headcount 37 linearly proportional 37 #.#mln rub [003] 37 FSP APB# 1 37 deemed uncollectible 37 Smecta ® 37 periodicity 37 thermodynamic stability 37 USUSD #.# 37 ARS# #mn 37 gadolinium enhancing 37 Postoperative complications 37 quantization 37 HY# 37 THB# #mn 37 negotiables 37 versus 37 nonaccruals 37 Lm#.# [002] 37 Rs5 #cr 37 P cadherin 37 TRY #.#bn [002] 37 Entangled photons 37 apoptosis pathway 37 Sawlog prices 37 YonY 37 psec 37 MD Buyline IDC 37 cytosolic 37 severalfold 37 adjusted OIBDA margin 37 Q2 FY'# 37 extracapsular 37 PCR primer 37 BGN #.#mn [003] 37 RUR#m 37 #.#mln rbl [001] 37 RUR#.#bn approx. [001] 37 serum estradiol 37 Newsstand Distribution Services 37 EUR#.#million 37 proforma revenues 37 Equity Investees 37 RUR#.#bn approx. USD#.#bn [005] 37 Consolidated adjusted EBITDA 37 Tecstar Automotive Group 37 rebased amounts 37 linearly 37 cards NICs 37 LTM EBITDA ratio 37 intersegment eliminations 37 Rs#.#mn [003] 37 table reconciles 37 OshKosh wholesale 37 invariant 37 quantified emission 37 Nasdaq adv dec 37 #bp qoq [001] 37 from# [001] 37 Ps.#.# [004] 37 Phosphates segment 37 signifying 37 initialise 37 Lm#.#m [002] 37 Adjusted EBITA 37 antlered harvest 37 Rs.#.# Crores [002] 37 totaled USD#.#m 37 unamortized portion 37 txt file 37 stent stenosis 37 #.#percentage points 37 Equinix excludes 37 CZK 2bn 37 Supplementary Appendix 37 logarithmic scale 37 depreciable asset 37 Currency translation negatively impacted 37 Sandblom click 37 H2 FY# 37 Ps.#.# [002] 37 numeric identifier 37 concatenated 37 Drivetrain segment 37 consolidated ADV 37 EBITDAO 37 thousand BOEPD 37 increa sed 37 continuingoperations 37 heterozygotes 37 EUR #.#mn [001] 37 Generally Accepted Accounting Principle 37 serum HCV RNA 37 LIFO inventory reserve 37 Fig. 3a 37 unrealized derivative 37 Time Charter Equivalent 37 Projections ranged 37 EDITDA 37 Marketwide rollover 37 Astaris joint venture 37 RMLs 37 cortical regions 37 accretion expense 37 #.# mil rub [001] 37 yearearlier 37 operating income1 37 passengers enplaned 37 hectoliters hl 37 Rs#.#cr [002] 37 SKK #.# [001] 37 VGBL 37 MtM impacts 36 gene ontology 36 #.# bln rbl [001] 36 RMB#.# billion [002] 36 #.#K trading [001] 36 HLA DRB1 36 Partially offsetting 36 #MFY# [002] 36 specifying 36 Core noninterest expense 36 NEPSE index 36 mouse scroll wheel 36 IDT Carmel 36 scintigraphic 36 margin teb 36 retrospectively restated 36 Interest Expense Interest expense 36 kilometer RPK 36 rebased revenue 36 IFEM 36 Q1 FY# [001] 36 toreflect 36 sq cm 36 constitutive 36 RMB#.# [009] 36 serum HBV DNA 36 predefined threshold 36 #.#mln rbl [002] 36 multiple logistic regression 36 Descriptive statistics 36 strontium isotopes 36 RUR USD 36 ENPP1 36 HY1 36 JPY#.# billion [001] 36 subtotals 36 c.# [003] 36 #.#.# #.#.# [004] 36 tibiofemoral 36 9M FY# [001] 36 afterload 36 applies prospectively 36 approximately RMB8 36 double digit growths 36 Fixed annuity 36 uL 36 Motorhome Resorts Segment 36 OREO valuation 36 per gigajoule GJ 36 Bt cotton acreage 36 changesin 36 severance accruals 36 overyear 36 ROACE 36 Fig. 2B 36 demonstrated clinically meaningful 36 Q2 FY# [001] 36 discrete cosine transform 36 decreasing 36 KEUR 36 including QSI equals 36 viral titer 36 #.#,#.# [002] 36 Kleros RE IV 36 proforma 36 totaled NIS 36 mm dd yyyy 36 statistically indistinguishable 36 TRY#.# [001] 36 Adjusted FIFO EBITDA 36 EURO#.# [001] 36 RMB3 #.# 36 aq q 36 KD#.#mn [002] 36 A#.# #.#c 36 excluding nonrecurring 36 RMB2 #.# 36 #.# mln rbl [002] 36 pretreatment baseline 36 phytosterol revenues 36 CEACAM1 36 iDeclare 36 SEK -#.# [003] 36 org domains 36 glacial interglacial 36 parenthesis 36 commemorative trinkets 36 MCDL 36 MSR valuation 36 posttest 36 caudal 36 Aggregated 36 Rs#.# crore [003] 36 Raman spectra 36 mln rbl vs. 36 mmscm 36 PV originations 36 Invoiced

Back to home page